Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
PETX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.27%150.842.8%$394.43m
ZTSZoetis, Inc. Class A
0.89%97.781.9%$222.62m
MYLMylan N.V.
0.32%28.183.2%$204.30m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.79%16.642.1%$167.62m
TXMDTherapeuticsMD, Inc.
1.28%5.5325.3%$19.35m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.36%39.012.0%$7.41m
TAROTaro Pharmaceutical Industries Ltd.
0.01%107.506.4%$6.95m
ABEOAbeona Therapeutics, Inc.
-0.12%8.097.8%$3.32m
JAGXJaguar Animal Health, Inc.
192.64%0.479.8%$2.26m
KINKindred Biosciences, Inc.
-3.49%8.850.3%$2.05m
LFVNLifeVantage Corporation
-2.47%14.603.3%$1.67m
PETXAratana Therapeutics, Inc.
4.10%3.818.5%$1.31m
CPHIChina Pharma Holdings, Inc.
-4.17%0.310.1%$0.31m

Company Profile

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.